Hinge Health (HNGE) Revenue & Revenue Breakdown
Hinge Health Revenue Highlights
Latest Revenue (Y)
$390.40M
Latest Revenue (Q)
$154.21M
Hinge Health Revenue by Period
Hinge Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $390.40M | 33.37% |
| 2023-12-31 | $292.73M | - |
Hinge Health generated $390.40M in revenue during NA 2024, up 33.37% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Hinge Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $154.21M | 10.87% |
| 2025-06-30 | $139.10M | 12.33% |
| 2025-03-31 | $123.83M | 5.60% |
| 2024-12-31 | $117.26M | 16.54% |
| 2024-09-30 | $100.61M | 12.01% |
| 2024-06-30 | $89.83M | 8.60% |
| 2024-03-31 | $82.71M | 1.45% |
| 2023-12-31 | $81.52M | 0.21% |
| 2023-09-30 | $81.35M | 16.48% |
| 2023-06-30 | $69.84M | - |
Hinge Health generated $154.21M in revenue during Q3 2025, up 10.87% compared to the previous quarter, and up 171.68% compared to the same period a year ago.
Hinge Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| OSCR | Oscar Health | $9.18B | $2.99B |
| LNTH | Lantheus | $1.53B | $384.01M |
| INDV | Indivior | $1.19B | $314.00M |
| HNGE | Hinge Health | $390.40M | $154.21M |
| WGS | GeneDx | $305.45M | $116.74M |
| PRAX | Praxis Precision Medicines | $8.55M | - |
| CRNX | Crinetics Pharmaceuticals | $1.04M | $143.00K |
| AKRO | Akero Therapeutics | - | - |
| VKTX | Viking Therapeutics | - | - |
| IMVT | Immunovant | - | - |
| DYN | Dyne Therapeutics | - | - |